Amelia Gallitano, MD, PhD, a physician-scientist at the University of Arizona College of Medicine – Phoenix, has received a grant to develop a novel diagnostic test for schizophrenia.Continue reading
Amelia Gallitano, MD, PhD, a physician-scientist at the University of Arizona College of Medicine – Phoenix, has received a grant to develop a novel diagnostic test for schizophrenia.Continue reading
Arizona’s biotech community will be telling its story at the largest annual convergence of life science innovators and investors during JPM18.Continue reading
Grant will support the largest interventional canine clinical trial ever conducted.Continue reading
New high school program joins successful Helios Scholars at TGen in preparing Arizona students for high-tech biomedical careersContinue reading
NuvOx Pharma, a clinical stage biotechnology company based in Tucson, Arizona, has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke (NINDS). This grant will fund development of a novel syringe sonication device that may allow quick preparation of an investigational drug for oxygen delivery.Continue reading
Signs Master Collaboration Agreement for Assay Development and Manufacturing of Kits Supporting Biomarker Research ProgramsContinue reading
The Fall 2017 round of the Arizona Innovation Challenge (AIC) has concluded as the Arizona Commerce Authority (ACA) today announced six awardees in its semi-annual business plan competition including Arizona biotech companies Life365, Inc. GT Medical Technologies, and Resonea.